Extended Data Fig. 7: Association between immunotherapy biomarkers and survival.

Association of pre-treatment (a) effector T cell IFNγ signature (n = 15 patients), (b) TMB (n = 22 patients), (c) PD-L1 expression (n = 34 patients), (d) neoantigen count (n = 18 patients), and (e) aneuploidy score (n = 22 patients) with progression-free (left) and overall survival (right). Variables were split at the median; two-sided Log-rank test.